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To determine whether the expression of cardiac genes changes in a
graded manner or by on/off switching when cardiac myocytes change
genetic programs in living animals, we have studied two indicator
genes that change their expression oppositely in mouse binucleate
ventricular cardiomyocytes during development and in response to
cardiac hypertrophy. One is a single-copy transgene controlled by an
-myosin heavy chain (aMHC) promoter and coding for CFP. The other
is the endogenous -myosin heavy chain (bMHC) gene modified to
code for a YFP–bMHC fusion protein. Using high-resolution confocal
microscopy, we determined the expression of the two indicator genes
in individual cardiomyocytes perinatally and after inducing cardiac
hypertrophy by transverse aortic constriction. Our results provide
strong evidence that the cardiac genes respond by switching their
expression in an on/off rather than graded manner, and that respond-
ing genes within a single cell and within the two nuclei of cardiomy-
ocytes do not necessarily switch concordantly.
gene switching  myosin heavy chain
Cells in different organ systems such as the heart commonlyrespond during development and after stress in adults by
changing their gene expression programs. The changes involve
multiple genes and can be in either direction. Substantial work
in the past decade has focused on the pathways governing gene
regulation and has uncovered molecular mechanisms that inte-
grate the actions of multiple cell surface receptors (1–3), signal
transduction pathways (4–6), and nuclear chromatin remodeling
(7–10) into changes in gene expression profiles (11). However,
important questions remain, including how expression varies in
different cardiac genes within the same cardiac myocyte and in
different myocytes within the heart. For example, it is not known
whether individual myocytes change their expression levels in a
graded manner or via an on/off-type switch (12). It is also not
known whether the expressions of responding genes change
coordinately or independently within individual myocytes.
A close to ideal system in which to answer these questions is
provided by the cardiac -myosin heavy chain (aMHC) and -
myosin heavy chain (bMHC) genes. These two isoforms are
normally expressed in a developmental stage-specific manner in
the mouse ventricle. Expression of bMHC predominates during
embryonic and fetal stages, at which stage the cells are mono-
nucleate. Expression of aMHC predominates soon after birth
(13), at which stage the cells are binucleate in the mouse (14, 15).
Reversal of this developmental change in expression occurs after
experimental cardiac hypertrophy, during which aMHC is down-
regulated, and bMHC is up-regulated. The response of the
cardiac ventricle to stress is accompanied by an increase in the
size of its myocytes without any appreciable increase in their
numbers (16). The hypertrophy-associated changes in gene
expression include many genes in addition to the MHC genes and
affect a variety of structural and functional features of the
myocytes, including their contractile efficiency, metabolic state,
and current-modulating ion channels (17–19).
To take advantage of this behavior of the MHC genes to
answer our questions, we used mice expressing a YFP-bMHC
fusion protein from a modified allele at the bMHC locus and a
CFP from a single-copy transgene at the hypoxanthine phos-
phoribosyltransferase locus (Hprt). We followed the expression
patterns of these two indicator genes in individual cells after the
induction of hypertrophy. Our results provide strong evidence
that changes in protein expression of cardiac genes are mediated
by switching on/off with the probability that a gene will switch
increasing in relation to local fibrosis, although the switching of
responding genes within a single cell and within the nuclei of
binucleated cardiomyocytes are not necessarily concordant
events. Our data are not consistent with expression changing
only in a graded manner.
Results
Generation of Transgenic Animals. To generate an indicator gene
(aMHC-CFP) that would change its expression during development
and in response to hypertrophy in a manner similar to that of an
endogenous gene, we generated mice with a single-copy transgene
targeted to the X-linked Hprt locus. The transgene consists of a
5.5-kb aMHC promoter driving expression of sequences encoding
CFP. This 5.5-kb promoter has been used extensively to direct
ventricle-specific expression of genes and is known to respond
appropriately to developmental and hypertrophic stimuli (20, 21).
(The GFP transgene upstream of the CFP transgene and separated
from the aMHC-CFP transgene by two chicken -globin HS4
insulators was intended for use in future experiments. The GFP
transgene is under the control of a 5.6-kb bMHC promoter, but
proved not to be expressed in the adult cardiac myocyte under any
conditions.) Single-copy CFP transgenic mice were generated by
gene targeting as illustrated in Fig. 1. We chose to target the
transgene to the Hprt locus because it is neutral for transgene
expression, as judged by previous work showing no notable stim-
ulatory or suppressive effects on transgene expression (22). Because
the transgene is a single copy, difficulties associated with multicopy
transgenes are avoided. Hemizygous males and homozygous fe-
males with this X-linked CFP transgene were used in the present
study; they are phenotypically normal.
The CFP Transgene Is Regulated in Vivo During Development Like the
Endogenous aMHC Gene. To determine whether our single-copy
CFP transgene at the Hprt locus is appropriately regulated in
vivo, we analyzed its expression pattern during neonatal devel-
opment. High-resolution confocal microscopy was used to assess
CFP fluorescence in the ventricles of neonatal pups of ages 1 and
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10 days. Supporting information (SI) Fig. S1 A shows the ex-
pression pattern of CFP in thick ventricular sections. Some, but
not all, cells in the day 1 pups express CFP at very low levels, as
indicated by the faint and patchy cyan fluorescence. By neonatal
day 10, CFP is expressed at high levels in virtually all cells (Fig.
S1B), a pattern that continues throughout adult age. This pattern
mirrors the reported expression pattern of the endogenous
aMHC gene (13), indicating that the CFP transgene changes its
expression in vivo during neonatal development like the endog-
enous aMHC gene.
The CFP Transgene Responds to Hypertrophy Like the Endogenous
aMHC Gene. To investigate the response to hypertrophic stimuli of
genes of interest, we induced hypertrophy in 6-month-old animals
by using transverse aortic constriction (TAC). This surgical proce-
dure causes chronic pressure overload, stimulates renin production
by the kidneys, and leads to left ventricular hypertrophy accompa-
nied by a shift from the adult to the fetal MHC isoforms. Controls
received sham treatment (similar surgery without TAC). The
animals in the TAC group responded with a significant increase in
their heart weight (HW)/body weight (BW) ratio (P  0.005) (Fig.
2A), with all of the echocardiographic hallmarks of decompensated
cardiac hypertrophy, including decreases in fractional shortening
and increases in left ventricular mass (Table S1).
To test whether the CFP transgene responds to hypertrophic
stress like the endogenous aMHC gene, we determined the expres-
sion of the two genes at the mRNA levels by using RT-PCR. As
expected from the hypertrophic state of the hearts, the average
expression levels of aMHC were significantly reduced (to 40% of
controls, P  0.0005) in the ventricles of animals in the TAC group
(Fig. 2B). Expression of the CFP transgene was reduced compa-
rably (to 40% of controls, P  0.0005), showing that the transgene
is responsive to the hypertrophic stimuli (Fig. 2C).
To test whether the CFP mRNA expression levels parallel the
expression levels of the native aMHC gene, we conducted
bivariate analyses of mRNA expression levels of CFP and aMHC
in the ventricles of individual animals. Fig. 2D illustrates the
resulting data as a scatterplot matrix of expression levels of CFP
and aMHC. Each point corresponds to an individual animal. The
plot demonstrates that expression of CFP at the organ level is
highly correlated (r  0.84, P  0.0005) with expression of
aMHC. Together, these data show that the CFP transgene
responds to hypertrophy like the endogenous aMHC gene.
The CFP Transgene Is Down-Regulated in Individual Cells Surrounding
Fibrosis. We have previously generated mice expressing a YFP-
bMHC fusion protein and have shown that the YFP-bMHC
allele, a fusion of YFP coding sequences to the endogenous
bMHC gene, faithfully tracks bMHC expression during devel-
opment and hypertrophy (23). This work also revealed that a
modest increase in bMHC expression occurs during aging. Both
the marked increase that occurs with hypertrophy and the
modest aging effect are correlated with fibrosis.
To test whether individual cells in which the CFP transgene is
down-regulated are also associated with increased fibrosis, we
counterstained ventricular sections with a fluorescently labeled
(Tritc) lectin, wheat germ agglutinnin (WGA). This lectin binds
to collagen and serves as an indicator of fibrosis (23, 24). Fig. 3
A and C shows CFP fluorescence at low power (Fig. 3A) and high
power (Fig. 3C), while Fig. 3 B and D show WGA fluorescence
in the same ventricular sections. Fig. 3 illustrates that the
down-regulation of the CFP transgene (solid ovals in Fig. 3C),
like the up-regulation of the YFP-bMHC gene, occurs in cells
close to or surrounded by regions with increased collagen (solid
ovals in Fig. 3D). In contrast, cells showing high levels of CFP
expression (dashed ovals in Fig. 3C) are surrounded by normal
levels of collagen (dashed ovals in Fig. 3D).
To quantitate these findings, confocal images of the left ventricles
from hypertrophic animals were scored for fibrotic and nonfibrotic
areas and for CFP fluorescence in discrete areas across sections of
the ventricles. Fig. 3E illustrates the resulting data in the form of a
scatterplot matrix of mean WGA pixel intensity per area against
Fig. 1. Generation of CFP transgenic animals. (Top) Schematic of the partially
deleted Hprt locus of BK4 cells (42). The dashed line represents the deleted
region. (Middle) Schematic of the targeting construct. (Bottom) Schematic of
the targeted locus. An aMHC promoter (P aMHC)-driven CFP gene is upstream
of a fragment of the human Hprt gene that includes its promoter (P Hprt) and
exons 1 and 2 (coding exons are gray, noncoding exons and promoters are
white). Details of the targeting construct have been described (42). GFPn
represents the coding region for GFP with a nuclear-locating sequence under
control of a 5.5-kb bMHC promoter sequence (P bMHC). The boxes labeled I
represent a 1.2-kb chicken -globin insulator. The schematics are not to scale.
Fig. 2. Induction of aMHC-CFP transgene expression during hypertrophy.
(A–C) Comparisons of HW/BW ratios (A) and mRNA expressions relative to
mean of control (Relative Exp) for aMHC (B) and CFP (C) from hearts of TAC
(filled bars) and control animals (open bars). Quantitative gene expressions
were determined by Taqman Real-Time PCR. (D) Bivariate analyses between
mRNA levels of the relative expression of CFP (Relative CFP Exp) and aMHC
(Relative aMHC Exp). Circles denote control animals (n  6), and solid triangles
represent TAC animals (4-week treatment, n  9). The scales of both axes are
logarithmic.
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mean CFP pixel intensity per area and demonstrates a highly
significant inverse correlation between WGA staining and CFP
expression (r  0.66, P  0.0001). To exclude the possibility that
cells with undetectable levels of CFP are dead, we counterstained
ventricular sections with fluorescent phalloidin, which binds to
actin, to determine the cytoarchitecture of the cells. As shown in
Fig. S2, cells that express undetectable levels of CFP (* in Fig. S2A)
show the architecture expected for living cells (* in Fig. S2B). Thus,
cells in which CFP levels change, like cells in which YFP-bMHC
levels change, occur in regions of the ventricles where there is
increased collagen deposition.
Expression of the Two MHC Indicator Genes Is Independently Con-
trolled in Individual Cells. To test whether our two myosin-related
indicator genes are coordinately regulated in individual cells, we
mated the CFP transgenic mice with mice expressing the YFP-
bMHC gene. Animals heterozygous for the YFP-bMHC gene and
hemizygous (if male) or homozygous (if female) for the X-linked
CFP transgene were submitted to TAC (4 and 8 weeks). We then
used quantitative confocal microscopy to visualize the expression of
the two indicator genes. To quantitate the protein expression in
individual cells from hypertrophic and control hearts, we deter-
mined the average pixel intensities of CFP and YFP in single cells.
Approximately seven images spanning the left ventricular free walls
of six hypertrophic and three untreated double heterozygote ani-
mals were acquired, and the average fluorescence intensities per
pixel of YFP and CFP in individual cells (19,000 cells total; 3,000
cells per TAC heart) were determined by using National Institutes
of Health program ImageJ.
Fig. 4 illustrates the resulting data as a scatterplot matrix of log2
of average YFP fluorescence (vertical axis) and log2 of average CFP
intensity (horizontal axis) of individual cells from untreated trans-
genic animals (Fig. 4A) and transgenic animals with TAC treatment
(Fig. 4B). The crossed vertical and horizontal lines in Fig. 4 are
drawn, respectively, two standard deviations to the left and above
the mean log2 CFP and mean log2 YFP intensities of the control
cells; 99% of the control cell populations (Fig. 4A) lie within the
lower right quadrant (a) formed by these lines. Fig. 4B shows that
after TAC the expression of the YFP fusion gene increases in some,
but not all, myocytes (38% of the points are now above the
horizontal line). Accompanying these increases in YFP expression,
the expression of CFP decreased (25% of the points are now left of
the vertical line). These data consequently demonstrate that, al-
though most of the cells in the ventricles of TAC-treated animals
are hypertrophic (23), the expression levels of the indicator genes
change in only some of them, and the two indicator genes do not
always change concordantly. More cells increase YFP expression
than decrease CFP expression.
Fig. 5 illustrates cells, close to areas of fibrosis, that correspond
to the four types of cells represented by the quadrants in Fig. 4B:
high CFP, low YFP (a); high CFP, high YFP (b); low CFP, high
YFP (c); and low CFP, low YFP (d). The lack of concordance is
further documented by noting that the fraction of cells in
quadrants d and b (31%) with only one of the genes changing
expression is approximately twice the fraction in quadrant c
(16%) with both genes changing expression.
To confirm our finding of a lack of concordance between CFP
and YFP expression, we conducted regression analysis of CFP
fluorescence against YFP fluorescence at the level of individual
cells (19,000), and the results show only a weak correlation
(Spearman rank test   0.22). This test indicates that the
changes in expression of CFP and YFP are largely independent
in individual cells. We conclude that TAC induces tissue-wide
changes in expression of the two indicator genes that are
inversely correlated at the level of individual ventricles, but at the
level of individual cells the changes in expression levels of the
two genes are not obligatorily coupled.
Changes in Expression of the CFP Indicator Gene Do Not Follow a
Graded Model. We next tested whether the CFP indicator gene
responds to the stresses of TAC in a graded manner or by on/off
switching. To make these tests we analyzed the fluorescence
intensity data to determine statistically whether the distributions
are unimodal or bimodal. If, after TAC, the indicator genes change
expression in a graded manner in all cells, the distribution of CFP
fluorescence intensities should shift downward and that of YFP
should shift upward but each distribution should remain unimodal.
If the changes are on/off, the distributions should become bimodal
(one population remaining unchanged, and the other changed).
Nonlinear regression analyses (25) enable comparisons between
models of varying complexity. Such analyses compare the statistical
merits of the better fit that always results from complexity (i.e.,
more parameters) versus the statistical penalty (more degrees of
freedom) imposed by the additional parameters. We applied tests
of this type to the data presented in Fig. 4 without constraining any
of the parameters. The tests show that the CFP fluorescence
intensities in untreated mice are well described by a single Gaussian
distribution, with the high mean intensity expected for a gene that
is strongly expressed (best-fit curve above the bivariate scatterplot
matrix in Fig. 4A). In contrast, the tests show that the CFP
intensities for the TAC-treated animals (Fig. 4B) are best described
by a trimodal distribution (P for bimodal versus trimodal  0.0001;
P for unimodal versus trimodal  0.0001). Thus the intensities of
CFP fluorescence in cardiomyocytes after TAC are best repre-
sented by three populations that differ in a stepwise manner, rather
Fig. 3. aMHC down-regulation is associated with fibrosis. (A–D) Confocal
images of a single vibratome transverse section from a transgenic TAC (4-week
treatment) heart imaged with a CFP filter (A and C) and a Tritc filter (B and D)
for WGA lectin, using 4 (A and B) or 20 (C and D) oil immersion objectives.
In A and B, squares indicate the regions that were imaged in C and D. In C and
D, solid ovals delineate cells with low levels of CFP and dashed ovals delineate
cells with high levels of CFP. (E) Bivariate analysis between log10 of mean CFP
pixel intensity [Log(Av. CFP intensity)] and log10 of mean WGA pixel intensity
[Log(Av. WGA intensity)]. (Scale bar: 50 microns.)











than by one or two populations with decreased mean levels of CFP
expression.
Table 1 and Figs. S3 and S4 present the results of the nonlinear
regression analyses for the nine animals whose data were pooled
to generate Fig. 4. The best-fit averages from the distributions of
cells in individual animals and the best-fit distributions of the cell
populations in the individual animals are close to those of the
pooled data. Table 1 also shows that the likelihood of finding one
or more populations of cells with changed CFP expression is
correlated with the HW/BW ratio (a measure of cardiac stress)
of the individual mice. We used two tests to assess whether this
correlation between the detection of more than one population
and the HW/BW ratio is significant. In one test, we considered
the number of populations (one, two, or three) detected in a
given animal as a continuous variable and regressed the number
of populations against the HW/BW ratio by standard linear
regression. In the other test, we considered the number of
populations as an ordinal number and assessed the correlation
by ordinal logistic regression. The linear regression gave R2 
0.6, P  0.01; the logistic regression gave P  0.004. Thus both
tests show that the likelihood of detecting a population of cells
with altered CFP expression in a given animal is correlated with
the degree of stress (HW/BW ratio) to its heart.
Table 1 shows, in addition, that the mean intensity of fluores-
cence of the intermediate population of cells is approximately
midway between the mean intensities of the high expression cells
(equivalent to cells from the untreated animals) and the cells with
the lowest level of CFP expression (most responsive cells); the
means of the three populations are significantly different (P  0.001).
Equivalent analyses for YFP expression in the cells of TAC hearts
show that the pooled data (Fig. 4B and Table 1) and the data from
the single animals (Fig. S4 and Table 1) can be described by either
a bimodal or trimodal distribution, but not by a unimodal distri-
bution (P  0.0001). The bimodal and trimodal distributions both
identify one population (the majority of cells) with a mean intensity
identical to that of the cells from the control animals and animals
with no transgenes (indicating a complete shutdown of YFP gene).
The bimodal and trimodal distributions identify two other popu-
lations, with means greater than the mean of the control population.
As in the case of CFP expression, one population has a mean
expression level approximately midway between the high and the
low expressing populations (Fig. 4B and Table 1). Individual
animals exhibit low, low plus intermediate, or intermediate plus
high populations. The mean intensities of the three populations are
consistent across the 11 animals and differ significantly (P  0.01).
Together, the CFP and YFP data reveal three discrete levels for
both indicator genes and show that expression changes in a stepwise
rather than a graded manner.
Discussion
In this article we describe experiments aimed at uncovering the
manner in which individual cardiac myocytes change the expres-
sion levels of different genes in response to external stimuli. We
chose to follow the changes in expression in cardiomyocytes of
two indicator genes related to the aMHC and bMHC genes
because of the well documented response of the two MHC genes
to chronic pressure overload on the heart. One of the two
indicator genes is a CFP transgene driven by the aMHC pro-
moter and inserted as a single copy into the Hprt locus. The other
A B
Fig. 4. MHC isoform switching. Bivariate scatterplots representing log2 of average pixel intensity per cell of CFP (x axis) and YFP (y axis) of ventricular cells in
transgenic animals with no treatment (A) and in transgenic mice treated with TAC (B). The crossed vertical and horizontal lines are drawn, respectively, two
standard deviations to the left and above the mean Log2 CFP and Log2 YFP intensities of the control cells. Contour lines in the data for TAC animals present
one-10th quantile values. Relative frequency (Rel. Freq.) of average CFP pixel intensity per cell (Upper) and average YFP pixel intensity intensity per cell (Lower)
are presented alongside each bivariate scatterplot. Solid lines represent the best-fit curves, and dashed lines represent the parameters of the constituent
populations determined by nonlinear regression analyses. Data represent 19,000 cells from six TAC hearts (4- and 8-week treatments, 3,000 cells per heart) and
three control hearts (800 cells per heart). The data for the nine individual animals that are included are presented in Fig. S3 and Fig. S4. The bimodal distribution
of YFP pixel intensity for the control animals is not caused by the presence of two populations in each animal, but is caused by small differences in YFP expression
between the different control animals that each show a unimodal distribution (Fig. S3).
Fig. 5. Confocal images of a single saggital vibratome section from a
transgenic TAC heart imaged with filters for CFP and YFP using a 60 objec-
tive. Merge image represents the merging of CFP and YFP. Arrows point to
cells that express CFP only (a), both CFP and YFP (b), YFP only (c), and neither
CFP nor YFP (d) and represent cells corresponding to each of the four quad-
rants defined in Fig. 4. (Scale bars: 50 microns.)
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is a modified form of the natural bMHC gene that produces a
YFP-bMHC fusion protein; this gene is at its normal chromo-
somal locus and has all of its normal introns and control elements
intact. Like the aMHC and bMHC genes, the two indicator genes
respond antithetically to the stress induced by TAC.
Our investigations reveal that the CFP and YFP indicator genes
are regulated discordantly in individual cells in vivo. Thus, we find
that myocytes with decreased CFP levels do not necessarily have
increased YFP levels, and vice versa, although we find a weak
negative correlation between the expression of the CFP and YFP
in individual cells. These observations are consistent with previous
suggestions that the MHC genes are independently controlled
(26–29). A recent report (30) suggests that re-expression of bMHC
is the indirect effect of down-regulation of aMHC mediated by a
microRNA, mir 208a, transcribed from an intron of the aMHC
gene. However, our aMHC CFP indicator transgene lacks this
intron, so that the weak correlation that we find between the
expressions of our indicator genes cannot be caused by this mi-
croRNA. We think it to be more likely because the expressions of both
genes are influenced by circumstances that promote fibrosis (23).
The most striking result of our study is the evidence it provides
that the changes in expression of indicator genes in the heart in
response to stress are mediated in an on/off rather than in a graded
fashion, and that each indicator exhibits a trimodal pattern of
expression. Thus in the hearts of animals subjected to TAC, we find
for each indicator gene a major population of hypertrophic cells that
have expression levels indistinguishable from the myocytes from
untreated hearts that have high CFP and low YFP expression. A
second population has expression levels midway between the first
population and those of a third population, which have low levels
of expression for CFP, and high levels of expression for YFP. This
trimodal distribution of fluorescence intensities is not compatible
with graded changes in the expression of the indicator genes. It is,
however, readily understood if genes in the binucleate cardiomyo-
cytes switch in an on/off manner that is not necessarily concordant.
Under this interpretation, the population with high levels of ex-
pression corresponds to cells with the indicator gene on in both
nuclei. The second population with intermediate levels of expres-
sion corresponds to cells with the indicator gene on in one nucleus
and off in the other. The third population with undetectable levels
of expression corresponds to cells with indicator genes off in both
nuclei. Previous studies (15) have shown that the vast majority
(91%) of the adult mouse cardiac myocytes are binucleate, and
Engelmannn et al. (31) have shown that multinucleate myocytes in
the adult rat heart are least frequent in the left ventricle compared
with the right ventricle and septum. Because our analyses were done
exclusively in the left ventricle of the hearts, the relative contribu-
tions of the few mononucleate or multinucleate myocytes that may
be present in the left ventricle are unlikely to have a major effect
on our overall analyses and conclusions.
There has been substantial theoretical discussion (12, 32, 33) and
experimental modeling (34–37) regarding the possibility that indi-
vidual genes are regulated in an on/off or in a graded manner in
individual cells. Our study provides evidence that on/off switching
occurs in cardiac myocytes and confirms other observations that
individual genes change expression in an on/off rather than graded
manner (38–40). Our inference that genes within an individual
cardiac myocyte nuclei can switch independently is consistent with
previous work demonstrating that not all nuclei within multinucle-
ate myotubes are transcriptionally active at a given time and that
different loci are regulated independently (41). Our working hy-
pothesis is that the switching we observe represents a change at the
level of chromatin that follows when all of several, perhaps many,
constantly associating and dissociating factors are transiently in the
correct state of modification (phosphorylation, acetylation, etc.)
and all are present on the relevant control regions at the same time.
There may be more than one transient constellation of bound
factors that is competent to induce the change in chromatin
configuration. If a competent constellation of bound factors occurs
only infrequently, then responding genes will appear to switch
stochastically. And in a binucleate cell the gene in one nucleus will
switch independently of the same gene in the other nucleus.
In summary, our results provide strong evidence that the changes
in expression of the indicator genes that we have studied are
accomplished by on/off switching, with the probability that a gene
will switch increasing in relation to stress, but with the switching of
responding genes within a single myocyte and within the nuclei of
binucleated cardiomyocytes being independent events.
Experimental Methods
Generation of Transgenic Animals. A 5.6-kb murine aMHC promoter and 5.5-kb
murine bMHC promoter (kind gifts of Jeffrey Robbins, University of Cincinnati,
Cincinnati) were used to drive the coding sequence of CFP and GFPn, respectively.
The reporter transgene was cloned into the Hprt targeting vector, a modified
version of pSKB1 (42). Cell culture, electroporation, selection, and microinjection
Table 1. Log2 of Mean fluorescence Intensities of the populations identified in individual animals
Animal description
Log2 CFP mean fluorescence intensity  SD Log2 YFP mean fluorescence intensity  SD
Low pop. Inter. pop. High pop. HW/BW Low pop. Inter. pop. High pop. HW/BW
1 No Ind., No Treat. 2.5  0.4 5.4 4.9  0.3 5.4
2 No Ind., No Treat. 2.3  0.2,
2.8  0.3
5.7 5.2  0.3 5.7
3 Ind., No Treat. 7.9  0.2 4.8 5.4  0.2 4.8
4 Ind., No Treat. 7.2  0.2,
6.9  0.3
5.5 4.7  0.3 5.5
5 Ind., No Treat. 7.3  0.2 5.8 5.2  0.5 5.8
6 Ind., TAC4 Weeks 7.1  0.3 9.3 5.3  0.4 6.2  0.8 9.3
7 Ind., TAC4 Weeks 5.0  1.8 6.6  0.4 7.0  0.2 14.7 4.9  0.3 5.3  0.9 14.7
8 Ind., TAC8 Weeks 7.0  0.4 7.5  0.3 7.6 5.6  0.2 6.4  0.5 7.6
9 Ind., TAC8 Weeks 5.4  1.3 6.6  0.4 9.2 5.3  0.3 6.3  0.5 9.2
10 Ind., TAC8 Weeks 3.9  0.3 5.6  0.9 6.7  0.4 10.5 * 6.7  0.6 7.5  0.4 10.5
11 Ind., TAC8 Weeks 6.7  0.2 7.4  0.6 10.6 5.8  0.2 6.6  0.8 10.6
ALL TAC cells 5.0  1.3 6.8  0.5 7.3  0.3 5.6  0.5 6.7  0.2 7.3  0.4
Indicator (Ind.) refers to animals having one copy of the YFP fusion gene and one copy (if males) or two copies (if females) of the X-linked CFP transgene. No
Indicator (No. Ind.) refers to WT animals with no fluorescence genes. Mean fluorescence intensities and SDs of each population were acquired from the
parameters of best-fit curves for each distribution as determined from nonlinear regression analyses. HW/BW indicates the HW to BW ratio (mg/g). Animals are
arranged in the increasing order of HW/BW ratios within their groups. The occurrence of two subpopulations of cells with different CFP intensities (animals 2,
No. Ind., No Treat., and 4, No Ind., No Treat.) are due to subtle changes in expression levels (see Fig. S3).











of ES cells were as described (42). Transgenic animals from chimeras were main-
tained in mixed 129Svev/C57BL/6 background. Generation of YFP-bMHC has
been described (23). The mice were maintained in a facility accredited by the
Association for the Assessment and Accreditation of Laboratory Animal Care
International according to Institutional Animal Care and Use Committee-
approved guidelines.
Morphometrical Analyses. To quantitatively analyze gene expression levels in
individual cells, hearts from WT (no transgene), control, and TAC (double het-
erozygote) animals were sectioned sagitally by using a vibratome and stained
with WGA lectin labeled with Alexa Fluor633 (23). Approximately seven images
each from the left ventricular free walls were acquired from an Olympus FV500
confocal microscope with a 20 objective. Cell boundaries were traced based on
WGA staining, and the average pixel intensities of YFP and CFP in individual cells
(3,000 cells per heart and 19,000 cells total for TAC; 800 cells per heart and
2,500 total for control) were acquired by using ImageJ.
Statistical Analyses. Average CFP and YFP pixel intensities of cells were analyzed
by nonlinear regression. Unimodal, bimodal, and trimodal populations were
fitted by using a modified version of JMP software (SAS Institute), and the three
models were compared by using F test with Graphpad Prizm software. The
parameters of each curve (means, standard deviations, and amplitudes) were
derived from the best-fit curves for the distributions determined by the nonlinear
regression analyses. Statistical calculations were performed with JMP software.
Linear and ordinal logistic regressions were carried out by considering the num-
ber of CFP populations, the dependent variable, either as a continuous or ordinal
numerical variable, and the HW/BW ratio as a continuous, independent variable.
TAC, echocardiography, gene expression analyses, and confocal image
analyses were conducted as described (23, 43). Animals of both genders were
used, and no differences between them were observed. Six-month-old mice
were used to minimize the effects of age-related changes in MHC expression.
For the data presented in Fig. 3E 15 areas each from three hearts were
analyzed; each individual area represents 1/50th ventricle.
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